HPAPIS AND CYTOTOXIC DRUGS MANUFACTURING MARKET ANALYSIS

HPAPIs and Cytotoxic Drugs Manufacturing Market, by Drug Origin (Chemical-based HPAPIs and Biologic-based HPAPIs), by Manufacturing Location (In-house Manufacturing and Outsourcing), by Drug Type (Novel HPAPIs and Generic HPAPIs), by Type of Pharmacological Molecule (Small Molecules and Biologics), by Application (Oncology, Respiratory, Ophthalmic Disorders, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : May 2022
Code : CMI1312
Pages :309
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global HPAPIs and Cytotoxic Drugs Manufacturing Market – Competitive Landscape

Major players operating in the global HPAPIs and cytotoxic drugs manufacturing market include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Lonza Group, CordenPharma International, Evonik Industries AG, Flamma Group, Merck KGaA, CARBOGEN AMCIS, Catalent, Inc., Piramal Enterprises Ltd., AbbVie Inc., Fareva Group, Cerbios-Pharma SA, Novasep, Ajinomoto Bio-Pharma, PCI Pharma Services, Sterling Pharma Solutions, Heraeus Holding, Polpharma Biologics, Helsinn Healthcare SA, Seqens, Cambrex Corporation.